Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

RTTNews | 458 дней спустя
Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

(RTTNews) - Amgen, Inc. (AMGN) announced Monday the opening of its manufacturing site in Central Ohio, the newest in its global operations network and the most advanced facility to date.

The nearly 300,000-square-foot facility will employ 400 full-time staff. It also features open workspaces to foster collaboration and has been designed to meet the highest environmental sustainability standards, in support of Amgen's commitment to achieve carbon neutrality for all operations by 2027.

In partnership with Columbus State Community College, Amgen is hosting an inaugural 18-month manufacturing apprenticeship at the site. This program, designed for those new to the field or changing careers, offers a blend of classroom and practical training, aiming to expand opportunities for skilled individuals without the requirement for a formal bachelor's degree.

Тэгов: AMGN
read more
Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...
RTTNews | 364 дней спустя
Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).
RTTNews | 1010 дней спустя
CAC 40 Moderately Higher Amid Easing Trade Tensions

CAC 40 Moderately Higher Amid Easing Trade Tensions

Amid easing trade war concerns following a U.S. court ruling against the sweeping tariffs announced by President Donald Trump, French stocks are moving higher on Thursday, recovering well after previous session's weakness.
RTTNews | 10 минут назад
DAX Modestly Higher As Trade Tensions Ease After U.S. Court Ruling

DAX Modestly Higher As Trade Tensions Ease After U.S. Court Ruling

German stocks are up in positive territory on Thursday amid easing trade tensions following a U.S. Federal Court ruling that President Donald Trump had overstepped his authority by imposing across-the-board duties on imports from U.S. trade partners.
RTTNews | 28 минут назад
Sensex, Nifty End Lackluster Session Modestly Higher

Sensex, Nifty End Lackluster Session Modestly Higher

Indian shares ended higher on Thursday, recovering from losses earlier in the session due to concerns over liquidity drain amid a wave of block deals initiated by promoters or private equity funds in recent sessions.
RTTNews | 39 минут назад
NVIDIA Stock Gains On Q1 Results; Sees $8 Bln China Impact

NVIDIA Stock Gains On Q1 Results; Sees $8 Bln China Impact

Shares of Nvidia Corp. gained around 5 percent in the extended trading on Wednesday and is currently up around 6 percent in the pre-market activity on the Nasdaq, after the artificial intelligence chipmaker reported significantly higher earnings in its first quarter, despite an expected $4.5 billion charge associated with H20 AI chip export barring to China. Revenues were 69 percent higher...
RTTNews | 1ч 11мин назад